Budesonide Inhalation Suspension
Product Images NDC 60687-524

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Budesonide Inhalation (NDC 60687-524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton

Carton
This is a product description for a medication called Budesonide Inhalation Suspension. It comes in a box containing 30x2mL unit-dose ampules, each in a foil pouch. The lot/exp number is not readable. The medication is intended for prescription use only. The instructions on how to use this medication are provided but are not readable in this text.*
FDA Label Image

Figure 1

Figure 1
The text describes a chart or table showing the change in nighttime asthma from baseline for different doses of a medication over a period of 12 weeks. The medication is dosed at 0.25 mg, 0.5 mg, and 1.0 mg once daily. The chart shows p-values for each dose, with the lowest p-value (indicating statistical significance) being for the 0.25 mg dose at 0.001.*
FDA Label Image

Figure 2

Figure 2
Nighttime Asthma Change from Baseline data is shown in the given text. However, due to incorrect reading, the information is not entirely reliable and may not be useful.*
FDA Label Image

Figure 3

Figure 3
This appears to be a table or chart showing the mean change from baseline in nighttime asthma symptoms over a 12 week period, with data for different dosages of a drug or placebo. P-values for each dosage are also provided.*
FDA Label Image

Foil

Foil
Budesonide inhalation suspension is a prescription medicine that contains 0.5 mg of budesonide in each 2 mL of sterile suspension delivered by a dose amped for inhalation only. The usual dosage is directed by a medical professional and should be followed by patients. Detailed instructions are available in the package insert. The medicine should be stored at a controlled room temperature of 20°-25°C (58°-77°F), with excursions permitted between 1 to 30°C (59"-86°F) as stated by the United States Pharmacopeia (USP). Once the foil pouch of unopened ampule is opened, use the ampule within the two weeks. The package contains one unit dose ampule per pouch. Inactive ingredients include anhydrous citric acid, disodium edetate dihydrate, polysorbate 80, sodium chloride, and water for injection. This medicine is manufactured by LUPIN PHAR and distributed by American Health Packaging in Columbus, Ohio. Keep the medicine, along with other drugs, out of children's reach.*
FDA Label Image

Ifu Figure 2

Ifu Figure 2
FDA Label Image

Ifu Figure 3

Ifu Figure 3
FDA Label Image

Ifu Figure 4

Ifu Figure 4
FDA Label Image

Structure

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.